ZA821525B - Cephalosporin antibiotics - Google Patents

Cephalosporin antibiotics

Info

Publication number
ZA821525B
ZA821525B ZA821525A ZA821525A ZA821525B ZA 821525 B ZA821525 B ZA 821525B ZA 821525 A ZA821525 A ZA 821525A ZA 821525 A ZA821525 A ZA 821525A ZA 821525 B ZA821525 B ZA 821525B
Authority
ZA
South Africa
Prior art keywords
cephalosporin antibiotics
cephalosporin
antibiotics
Prior art date
Application number
ZA821525A
Other languages
English (en)
Inventor
William Henry Walker Lunn
John Kevin Shadle
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA821525B publication Critical patent/ZA821525B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA821525A 1981-03-11 1982-03-08 Cephalosporin antibiotics ZA821525B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/242,792 US4336253A (en) 1981-03-11 1981-03-11 Cephalosporin antibiotics

Publications (1)

Publication Number Publication Date
ZA821525B true ZA821525B (en) 1983-03-30

Family

ID=22916202

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA821525A ZA821525B (en) 1981-03-11 1982-03-08 Cephalosporin antibiotics

Country Status (21)

Country Link
US (1) US4336253A (fr)
EP (1) EP0060144A3 (fr)
JP (1) JPS57165393A (fr)
KR (1) KR830009119A (fr)
AU (1) AU8091182A (fr)
BG (1) BG36936A3 (fr)
CA (1) CA1177066A (fr)
CS (1) CS238620B2 (fr)
DD (1) DD201599A5 (fr)
DK (1) DK100982A (fr)
ES (1) ES510307A0 (fr)
FI (1) FI820806A7 (fr)
GB (1) GB2094309B (fr)
GR (1) GR74714B (fr)
IL (1) IL65185A0 (fr)
NZ (1) NZ199959A (fr)
PH (1) PH17022A (fr)
PL (1) PL130568B1 (fr)
PT (1) PT74558B (fr)
RO (1) RO82962B (fr)
ZA (1) ZA821525B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443444A (en) * 1980-08-11 1984-04-17 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
DE3118732A1 (de) * 1981-05-12 1982-12-02 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
US4450270A (en) * 1981-10-02 1984-05-22 Eli Lilly And Company Dioximino cephalosporin antibiotics
US4616081A (en) * 1982-07-07 1986-10-07 Asahi Kasei Kogyo Kabushiki Kaisha Cephalosporin compounds
DE3316798A1 (de) * 1983-05-07 1984-11-08 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von cephemverbindungen
DE3316797A1 (de) * 1983-05-07 1984-11-08 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von cephemverbindungen
ATE177104T1 (de) * 1984-11-23 1999-03-15 Biochemie Gmbh Cephalosporinderivative
US4703118A (en) * 1985-04-08 1987-10-27 Eli Lilly And Company Synthesis of 3-iodomethyl cephalosporins
US4714760A (en) * 1985-08-20 1987-12-22 Bristol-Myers Company Cephalosporin intermediates
US4749522A (en) * 1985-10-31 1988-06-07 Angio-Medical Corporation Supercritical fluid extraction of animal derived materials
US4868294A (en) * 1986-07-11 1989-09-19 Bristol-Myers Company Process for preparing cephalosporin intermediates
US7847093B2 (en) * 2003-04-16 2010-12-07 Sandoz Ag Processes for the preparations of cefepime
EP1618114B1 (fr) 2003-04-16 2010-07-14 Sandoz AG Procedes de preparation de cefepime
WO2006008749A1 (fr) * 2004-07-16 2006-01-26 Hetero Drugs Limited Procede de preparation d'intermediaires de cephalosporine pures
PT3616695T (pt) 2011-09-09 2024-11-18 Merck Sharp & Dohme Ceftolozano/tazobactam para tratar infeções intrapulmonares
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274996A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Tazobactam and ceftolozane antibiotic compositions
PE20160048A1 (es) 2013-03-15 2016-02-12 Merck Sharp & Dohme Composiciones antibioticas de ceftolozano
WO2015035376A2 (fr) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Traitement d'infections au moyen de ceftolozane/tazobactam chez des sujets ayant une fonction rénale altérée
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3792047A (en) * 1971-12-07 1974-02-12 Glaxo Lab Ltd N-(7,2'-thienylacetamidoceph-3-em-3-ylmethyl)-3"or 4"-n-hydroxyloweralkylcarbamoyl-pyridinium-4-carboxylates
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
JPS52125188A (en) 1976-04-14 1977-10-20 Takeda Chem Ind Ltd Cephalosporin derivatives and their preparation
DE2715385A1 (de) * 1976-04-14 1977-11-10 Takeda Chemical Industries Ltd Cephalosporinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
JPS6011713B2 (ja) * 1976-09-08 1985-03-27 武田薬品工業株式会社 セフアロスポリン誘導体およびその製造法
GB2027692B (en) 1978-05-26 1983-02-09 Glaxo Group Ltd Cephalosporin antibiotics
AR228726A1 (es) * 1978-05-26 1983-04-15 Glaxo Group Ltd Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato
ZA792581B (en) 1978-05-26 1981-01-28 Glaxo Group Ltd Cephalosporin antibiotics
NL8001087A (nl) 1979-02-23 1980-08-26 Glaxo Group Ltd Cefalosporine antibiotica.
US4237128A (en) * 1979-04-12 1980-12-02 E. R. Squibb & Sons, Inc. 7-[2-(2-Amino-4-thiazolyl)-2-[(1-carboxy-1,1-dialkyl)alkoxyimino]acetamido]cephem sulfoxides

Also Published As

Publication number Publication date
NZ199959A (en) 1985-08-16
FI820806L (fi) 1982-09-12
ES8303426A1 (es) 1983-02-01
US4336253A (en) 1982-06-22
RO82962B (ro) 1984-01-30
KR830009119A (ko) 1983-12-17
ES510307A0 (es) 1983-02-01
AU8091182A (en) 1982-09-16
CA1177066A (fr) 1984-10-30
IL65185A0 (en) 1982-05-31
CS238620B2 (en) 1985-12-16
PL235396A1 (fr) 1982-09-27
PT74558A (en) 1982-04-01
GB2094309B (en) 1985-03-27
FI820806A7 (fi) 1982-09-12
PT74558B (en) 1984-11-27
EP0060144A2 (fr) 1982-09-15
EP0060144A3 (fr) 1983-09-14
DD201599A5 (de) 1983-07-27
PL130568B1 (en) 1984-08-31
RO82962A (fr) 1984-01-14
GB2094309A (en) 1982-09-15
JPS57165393A (en) 1982-10-12
PH17022A (en) 1984-05-11
GR74714B (fr) 1984-07-06
BG36936A3 (bg) 1985-02-15
DK100982A (da) 1982-09-12

Similar Documents

Publication Publication Date Title
GB2094309B (en) Cephalosporin antibiotics
GB2106905B (en) Dioximino cephalosporin antibiotics
GB2123414B (en) Cephalosporin antibiotics
GB2084144B (en) Bis-tetrazoylmethyl substituted cephalosporin antibiotics
GB2132193B (en) Cephalosporin antibiotics
AU7959382A (en) Cephalosporin antibiotics
ZA833616B (en) Cephalosporin antibiotics
GB8317618D0 (en) Cephalosporin antibiotics
ZA825707B (en) Beta-lactam antibiotics
AU8851082A (en) Cephalosporin antibiotics
IL69108A0 (en) Cephalosporin antibiotics
IE820546L (en) Cephalosporin antibiotics
IL69109A0 (en) Cephalosporin antibiotics
AU8850982A (en) Cephalosporin antibiotics
GB8315929D0 (en) Cephalosporin antibiotics
GB8334601D0 (en) Cephalosporin antibiotics
GB8312676D0 (en) Cephalosporin antibiotics
GB8334599D0 (en) Cephalosporin antibiotics
IE831513L (en) Cephalosporin antibiotics
IE831514L (en) Cephalosporin antibiotics
GB8307586D0 (en) Cephalosporin antibiotics
GB8307585D0 (en) Cephalosporin antibiotics
GB8315930D0 (en) Cephalosporin antibiotics
GB8307584D0 (en) Cephalosporin antibiotics
GB8334600D0 (en) Cephalosporin antibiotics